- Details
- Christina Curtis shares insights from her work on breast and gastrointestinal cancers, discussing their potential application to prostate cancer. The focus of her discussion revolves around innovative strategies for defining biomarkers of therapy response using spatial proteomic approaches. Dr. Curtis describes how this new technology lets researchers examine the composition of tumor cells and the...
|
- Details
- Ravi Madan discusses the importance of patient-reported outcomes in prostate cancer research. He highlights a presentation centered around the CHAARTED study, which indicated that the three-month quality of life assessment was essential to understanding survival benefits of treatments for prostate cancer patients. In other studies, Dr. Madan notes the limitations of current quality of life metrics...
|
- Details
- Oliver Sartor discusses the rapidly evolving landscape of radiopharmaceuticals for prostate cancer with Alicia Morgans. Dr. Sartor highlights significant advances, such as the VISION trial, which targets late-stage patients and the PSMAfore trial focusing on pre-chemo patients. He emphasizes the importance of several ongoing trials that could change practice, including one using PSMA lutetium to t...
|
- Details
- Hiten Patel talks about the significant role of the Veterans Health Administration in prostate cancer treatment and research. Dr. Patel outlines the formation of prostate cancer centers of excellence within the VA, intended to coordinate efforts to improve oncology care and survival rates for veterans. The Precision Oncology Program for the Cancer of the Prostate (POPCaP), created in partnership w...
|
- Details
- Veda Giri discusses the promising results of the TARGET study in an interview with Alicia Morgans. The study examined an innovative web-based approach to expand genetic testing access for prostate cancer patients. The study addressed the lack of sustainable patient-genetic counselor interaction by implementing a patient-driven web tool, which was proven to be non-inferior to traditional genetic co...
|
- Details
- Stacy Loeb shares her significant research on the impact of plant-based diets on prostate cancer risk. The conversation pivots around Dr. Loeb's study which builds on earlier findings that higher plant-based food consumption correlates with lower fatal prostate cancer risk. Her newer research explores the potential benefits of such diets on quality-of-life outcomes post-diagnosis, especially with...
|
- Details
- Petros Grivas hosts a conversation with Hiba Khan, who has earned the prestigious ASCO Young Investigator Award for her work on financial toxicity in prostate cancer patients. Dr. Khan discusses the increasing cost of cancer treatments and the financial hardships that patients experience. This topic is also central to her review article published in the Journal of Clinical Oncology, which offers g...
|
- Details
- Ruchika Talwar converses with Avinash Maganty about his study on Practice Competition and Treatment of Newly Diagnosed Prostate Cancer. They delve into the healthcare industry's shift from independent to employed physicians, especially in urology. This trend towards larger, consolidated practices could influence care decisions in areas with discretionary care, such as prostate cancer. The study us...
|
- Details
- Andrea Miyahira interviews JJ Haijing Zhang on her research exploring the genomic alterations in prostate cancer patients exposed to Agent Orange. Agent Orange, an herbicide used by the US military during the Vietnam War, is linked to various health toxicities, including prostate cancer. Dr. Zhang's study aims to identify any specific somatic alterations related to Agent Orange exposure. The resea...
|
- Details
- In this discussion, Alicia Morgans interviews Ravi Parikh about his session on interventions to prevent or mitigate frailty in prostate cancer patients. Dr. Parikh emphasizes the necessity of screening for frailty and tailoring treatment strategies for older patients who may experience different side effects. He elaborates on strategies such as prehabilitation before prostate cancer surgery and ad...
|
